Georgetown Clinical Trial of Nilotinib in Alzheimer’s Disease Begins
 

The GU Alzheimer's trial for Nilotinib has begun recruiting. I anticipate the Parkinson's trial to get underway soon. This will be a single site study for patients living in the vicinity of GU. The multi site trial funded by MJFF et al will be led by Northwestern U. with 20 - 25 test sites throughout the country. That will likely get underway midyear.